Akari Therapeutics Plc: Akari Therapeutics, Plc Announces $4 Million Registered Direct Offering
Offering includes 100% participation by Akari's Board of Directors, including Akari President and CEO Rachelle JacquesOffering includes accredited investors who have not previously participatedDefinitive
Source: finanznachrichten.de